Alora Medical RespiPEP Award Receives Global Recognition

By João L. Carapinha

June 2, 2026

Alora Medical RespiPEP Award

Alora Medical RespiPEP Award marks a major milestone for the South African firm, which earned the Best Lung Clearing Device Brand 2026 title at the Global Health & Pharma Healthcare & Pharmaceutical Awards for its RespiPEP range. This achievement underscores the company’s role in expanding access to effective respiratory care across the region.

The Alora Medical RespiPEP Award highlights rising interest in non-invasive tools that support airway clearance and lung rehabilitation. Devices such as RespiPEP Therafizz and RespiPEP Theravance deliver Positive Expiratory Pressure therapy to improve lung volume, ease hyperinflation, and clear secretions in chronic respiratory conditions.

Regulatory Strength Behind the Devices

Alora Medical operates as a SAHPRA-licensed manufacturer, ensuring its RespiPEP products meet strict quality standards while remaining available through hospitals and clinics in South Africa and neighbouring countries. All devices require oversight by qualified healthcare professionals.

Market Opportunities for Affordable Lung Care

The recognition may open doors for wider adoption of cost-effective Positive Expiratory Pressure solutions, supporting preventive lung health and post-operative recovery programmes. It also strengthens the case for reimbursement frameworks that value accessible, clinically proven respiratory technologies.

Reference url

Recent Posts

Lingjian Morphology Diagnostics
Lingjian Morphology Diagnostics Transforming Clinical Laboratory Practices

By HEOR Staff Writer

June 22, 2026

Lingjian Morphology Diagnostics transforms microscopic analysis in clinical laboratories by uniting image interpretation, cell classification, morphological description, target localization, and natural language interaction within a single vision-language architecture. Developed to overcome pract...
vulnerable elderly care
Mapping Vulnerable Elderly Care in the Netherlands

By HEOR Staff Writer

June 22, 2026

As the Netherlands confronts rapid societal aging, effective vulnerable elderly care has become an urgent policy priority. One in four community-dwelling adults aged 65 and older lives with vulnerable health, according to Longitudinal Aging Study Amsterdam (LASA) data, marking a critical target g...
Joint Scientific Consultation EU
Joint Scientific Consultation EU Strategies for Medical Device Companies

By João L. Carapinha

June 19, 2026

The EU Joint Scientific Consultation gives medical device developers a voluntary route to obtain targeted feedback on clinical evidence plans well before formal Joint Clinical Assessment and national reimbursement decisions. Manufacturers of select high-risk technologies can align their developme...